Mitochondrial dysfunction and neuromuscular disease

Muscle and Nerve

Volumn 24, Issue 2, 2001, Pages 170-191

  Nardin, Rachel A ^a   Johns, Donald R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

DNA; Mitochondria; Mitochondrial; Neuromuscular diseases; Peripheral nervous system diseases; Review

Indexed keywords

MITOCHONDRIAL DNA;

CELL DEATH; CITRIC ACID CYCLE; ENERGY METABOLISM; EXERCISE TOLERANCE; FATTY ACID OXIDATION; GENETICS; GLYCOLYSIS; HUMAN; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; NEUROMUSCULAR DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW;

HUMANS; MITOCHONDRIAL MYOPATHIES; NEUROMUSCULAR DISEASES;

EID: 85047697283     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4598(200102)24:2<170::AID-MUS30>3.3.CO;2-S     Document Type: Review

References (220)

1. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA
2. Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders
3. Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study
4. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy
5. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy
6. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin
7. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion
8. Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-coxidase. A new mitochondrial multisystem disorder
9. Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies
10. Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion
11. Mitochondrial dysfunction in neurodegenerative diseases
12. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies
13. Mitochondrial dysfunction in multiple symmetrical lipomatosis
14. Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study
15. Abnormal RNA processing associated with a novel tRNA mutation in mitochondrial DNA. A potential disease mechanism
16. Myoclonus epilepsy with ragged red fibers and multiple mtDNA deletions
17. Decline with age of the respiratory chain activity in human skeletal muscle
18. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy
19. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency
20. Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10
21. Ubidecarenone in the treatment of mitochondrial myopathies: A multi-center double-blind trial
22. Effects of physical activity and age on mitochondrial function
23. Kearns-Sayre syndrome associated with mitochondrial DNA deletion or duplication: A molecular genetic and pathological study
24. The clinical and biochemical spectrum of human pyruvate dehydrogenase complex deficiency
25. The mitochondrial DNA C3303T mutation can cause cardiomyopathy and/or skeletal myopathy
26. Ekbom's syndrome: Lipomas, ataxia, and neuropathy with MERRF
27. Treatment of mitochondrial diseases
28. Mitochondrial DNA deletion in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes (MELAS) and Fanconi's syndrome
29. Clinical heterogeneity associated with mitochondrial DNA depletion in muscle
30. Sporadic MERRF/MELAS overlap syndrome associated with the 3243 tRNA (Leu[UUR]) mutation of mitochondrial DNA
31. Bilateral striatal necrosis and MELAS associated with a new T3308C mutation in the mitochondrial ND1 gene
32. Leigh syndrome associated with the T9176C mutation in the ATPase 6 gene of mitochondrial DNA
33. Mitochondrial encephalopathy with multiple mitochondrial DNA deletions: A report of two families and two sporadic cases with unusual clinical and neuropathological features
34. A mitochondrial DNA tRNA(Val) point mutation associated with adult-onset Leigh syndrome
35. A novel mitochondrial tRNA isoleucine gene mutation causing chronic progressive external ophthalmoplegia
36. Peripheral neuropathy in mitochondrial encephalomyopathies
37. Mutations in the X-linked E1 alpha subunit of pyruvate dehydrogenase leading to deficiency of the pyruvate dehydrogenase complex
38. MELAS: Clinical features, biochemistry, and molecular genetics
39. Reversal of a mitochondrial DNA defect in human skeletal muscle
40. Mitochondrial myopathy with atypical subacute presentation
41. Multiple symmetric lipomatosis: Evidence for mitochondrial dysfunction
42. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease
43. Exercise training programs and cardiorespiratory adaptation
44. Ocular myopathy (progressive external ophthalmoplegia) with neuropathic complications
45. Respiratory failure revealing mitochondrial myopathy in adults
46. Mitochondrial myopathy caused by long-term zidovudine therapy
47. Mitochondrial encephalomyopathies: What next?
48. Mitochondria in neuromuscular disorders
49. Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case
50. Mitochondrial myopathies
51. Fatal infantile mitochondrial myopathy and renal dysfunction due to cytochrome-c-oxidase deficiency
52. Mitochondrial encephalomyopathies
53. Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency
54. Ophthalmoplegia plus. The neurodegenerative disorders associated with progressive external ophthalmoplegia
55. Maternally transmitted partial direct tandem duplication of mitochondrial DNA associated with diabetes mellitus
56. 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle
57. Defective gene in lactic acidosis: Abnormal pyruvate dehydrogenase E1 alpha-subunit caused by a frame shift
58. Sensory, motor, and autonomic neuropathy in patients with multiple symmetric lipomatosis
59. Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease
60. Polyneuropathy in the mtDNA base pair 3243 point mutation
61. Ophthalmologic manifestations in MELAS syndrome
62. Electrophysiological findings including single fibre EMG in a family with mitochondrial myopathy
63. Glucose metabolism alterations in Friedreich's ataxia
64. Cell death and the mitochondrial encephalomyopathies
65. A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy
66. Polyneuropathy in progressive external ophthalmoplegia
67. Mitochondrial myopathies: Divergences of genetic deletions, biochemical detects and the clinical syndromes
68. Carnitine palmitvltransferase deficiency with permanent weakness
69. Sural nerve biopsy studies in Leigh's subacute necrotizing encephalomyelopathy
70. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): A correlative study of the clinical features and mitochondrial DNA mutation
71. Chronic progressive external ophthalmoplegia: A correlative study of mitochondrial DNA deletions and their phenotypic expression in muscle biopsies
72. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)
73. A novel point mutation in the mitochondrial tRNA(Leu) (UUR) gene in a family with mitochondrial myopathy
74. A new point mutation at nucleotide pair 3291 of the mitochondrial tRNA(Leu[UUR]) gene in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS)
75. Mitochondria and apoptosis
76. Demyelinating radiculopathy in the Kearns-Sayre syndrome: A clinicopathological study
77. The mitochondrial DNA transfer RNA(Lys)A→G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA
78. The mitochondrial DNA transfer RNALeu(UUR)A→G(3243) mutation. A clinical and genetic study
79. Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus: Different phenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation
80. MELAS: A new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity
81. Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA
82. Acute peripheral neuropathy, rhabdomyolysis, and severe lactic acidosis associated with 3243 A to G mitochondrial DNA mutation
83. Point mutations in mitochondrial tRNA genes: Sequence analysis of chronic progressive external ophthalmoplegia (CPEO)
84. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder
85. Coenzyme Q10 in a woman with myopathy, recurrent myoglobinuria, and seizures
86. Mitochondrial myopathies: Clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA
87. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy
88. Characterization of the mitochondrial DNA abnormalities in the skeletal muscle of patients with inclusion body myositis
89. Mitochondrial encephalomyopathy (MELAS): Pathological study and successful therapy with coenzyme Q10 and idebenone
90. Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients
91. A case of mitochondrial myopathy, encephalopathy and lactic acidosis due to cytochrome c oxidase deficiency with neurogenic muscular changes
92. Late-onset mitochondrial myopathy
93. Recurrent respiratory failure in a patient with 3243 mutation in mitochondrial DNA
94. An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p
95. A new mitochondrial DNA mutation associated with mitochondrial myopathy: tRNA(Leu)(UUR) 3254C-to-G
96. A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria
97. Polyneuropathy in the mtDNA base pain 3243 point mutation
98. Multiple symmetric lipomatosis: Abnormalities in complex IV and multiple deletions in mitochondrial DNA
99. Low levels of mitochondrial transcription factor A in mitochondrial DNA depletion
100. A new disease-related mutation for mitochondrial encephalopathy lactic acidosis and strokelike episodes (MELAS) syndrome affects the ND4 subunit of the respiratory complex I
101. Chronic intestinal pseudoobstruction with myopathy and ophthalmoplegia: A muscular biochemical study of a mitochondrial disorder
102. Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy
103. Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: Neuropathology, biochemistry, and molecular genetics
104. Sequencing and quantitative assessment of mutant and wild-type mitochondrial DNA in paraffin sections from cases of MELAS
105. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory chain control: A correlated clinical, biochemical and morphological study
106. Identification of a mutation in the mitochondrial tRNA(Cys) gene associated with mitochondrial encephalopathy
107. A new mutation associated with MELAS is located in a mitochondrial DNA polypeptidecoding gene
108. High levels of mitochondrial DNA with an unstable 260-bp duplication in a patient with a mitochondrial myopathy
109. In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF)
110. Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease
111. Muscle-nerve involvement in autosomal dominant progressive external ophthalmoplegia with hypogonadism
112. Fatal infantile mitochondrial myopathy due to cytochrome c oxidase deficiency
113. Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA
114. Peripheral neuropathy of mitochondrial myopathies
115. Familial mitochondrial myopathy associated with peripheral neuropathy: Partial deficiencies of complex I and complex IV
116. A mitochondrial tRNA anticodon swap associated with a muscle disease
117. Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Len [UUR]) gene an etiologic hot spot?
118. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome
119. Molecular analysis of the muscle pathology associated with mitochondrial DNA deletions
120. mtDNA depletiou with variable tissue expression: A novel genetic abnormality in mitochondrial diseases
121. Mitochondrial diseases
122. The molecular pathology of respiratorychain dysfunction in human mitochondrial myopathies
123. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy
124. Analysis of multiple mitochondrial DNA deletions in inclusion body myositis
125. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with acanthocytosis: A clinicopathological study of a unique case
126. Cytochrome c oxidase deficient fibres in the limb muscle and diaphragm of man without muscular disease: An age-related alteration
127. The retinal manifestations of mitochondrial myopathy. A study of 22 cases
128. A novel point mutation in the mitochondrial tRNA(Ser[UCN]) gene detected in a family with MERRF/MELAS overlap syndrome
129. Mitochondrial dysfunction with myoclonus epilepsy and ragged-red fibers point mutation in nerve, muscle, and adipose tissue of a patient with multiple symmetric lipomatosis
130. Neurological nanifestation in multiple symmetric lipomatosis; a clinical and electrophysiological study
131. A new mitochondrial DNA mutation associated with progressive dementia and chorea: A clinical, pathological, and molecular genetic study
132. Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome oxidase deficiency: A 31P NMR study
133. The 3260 mutation in mitochondrial DNA can cause mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS)
134. A novel mutation in the mitochondrial tRNA(Thr) gene associated with a mitochondrial encephalomyopathy
135. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder
136. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy
137. Treatment of Kearns-Sayre syndrome with coenzyme Q10
138. An autopsy case of MELAS [mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episode]
139. Mitochondrial DNA deletions in inherited recurrent myoglobinuria
140. Myoclonus epilepsy associated with ragged-red fibers: A G-to-A mutation at nucleotide pair 8363 in mitochondrial tRNA(Lys) in two families
141. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene
142. MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: Correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin
143. The clinical features of mitochondrial myopathy
144. Neuropathy and mitochondrial myopathy
145. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies
146. Peripheral neuropathy in mitochondrial disease
147. Neuropathy in multiple symmetric lipomatosis. Madelung's disease
148. Frataxin gene of Friedreich's ataxia is targeted to mitochondria
149. Leigh syndrome: Clinical features and biochemical and DNA abnormalities
150. Ragged red fibers in normal aging and inflammatory, myopathy
151. Kearns-Sayre syndrome and complex II deficiency
152. Mitochondrial myopathies: Genetic mechanisms
153. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
154. Progressive external ophthalmoplegia and ocular myopathies
155. Demyelinating polyneuropathy in a patient with the tRNA(Leu) (UUR) mutation at base pair 3243 of the mitochondrial DNA
156. Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: A study of 56 patients
157. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome
158. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS
159. Maternally inherited encephalopathy associated with a single-base insertion in the mitochondrial tRNATrp gene
160. Heterogeneous clinical presentation of the mtDNA NARP/T8993G mutation
161. Ultrastructure of swollen proximal axons of anterior horn neurons in motor neuron disease
162. A mitochondrial encephalomyopathy with specific deficiencies of two respiratory chain polypeptides and a circulating autoantibody to a mitochondrial matrix protein
163. Mitochondrial myopathy with a defect of mitochondrial-protein transport
164. Neuropathy associated with mitochondrial disorders
165. Mitochondrial abnormalities and peripheral neuropathy in inflammatory myopathy, especially inclusion body myositis
166. Mitochondrial abnormalities in human sural nerves: Fine structural evaluation of cases with mitochondrial myopathy, hereditary and nonhereditary neuropathies, and review of the literature
167. Chronic progressive external ophthalmoplegia is associated with a novel mutation in the mitochondrial tRNA(Asn) gene
168. Secondary mitochondrial pathology
169. Replacement therapy is effective in familial mitochondrial encephalomyopathy with muscle Coenzyme Q10 deficiency
170. Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: Clinical, morphologic, and biochemical studies
171. Mitochondrial encephalomyopathy associated with a novel mutation in the mitochondrial tRNA(leu) (UUR) gene (A3243T)
172. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation
173. Clinical features associated with the a→G transition at nucleotide 8344 of mtDNA ("MERRF mutation")
174. A new mtDNA mutation in the tRNA(Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF)
175. A novel mitochondrial DNA point mutation in the tRNA(Ile) gene is associated with progressive external ophthalmoplegia
176. Polyneuropathy, ophthalmoplegia, leukoencephalopathy, and intestinal pseudo-obstruction: POLIP syndrome
177. Studies on the inhibition of mitochondrial DNA replication by 3′-azido-3′-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication
178. Disorders of the pyruvate dehydrogenase complex
179. An autosomal locus predisposing to deletions of mitochondrial DNA
180. Mitochondrial myopathy associated with sudden death in young adults and a novel mutation in the mitochondrial DNA leucine transfer RNA(UUR) gene
181. Novel mutations associated with carnitine palmitoyltransferase II deficiency
182. Effects of aerobic training in patients with mitochondrial myopathies
183. Paralytic ileus and atonic bladder in a case of mitochondrial encephalomyopathy - Electrophysiological, chemical and pathological study with evidence of the peripheral nerve involvement
184. Mitochondrial mutation in fatal infantile cardiomyopathy
185. Identification of a common mutation in the carnitine palmitoyltransterase II gene in familial recurrent myoglobinuria patients
186. Heteroplasmic mtDNA mutation (T - G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high
187. A novel mitochondrial DNA point mutation in the tRNA(Ile) gene: Studies in a patient presenting with chronic progressive external ophthalmoplegia and multiple sclerosis
188. Treatment of mitochondrial disease
189. MELAS associated with a mutation in the valine transfer RNA gene of mitochondrial DNA
190. Demyelinating neuropathy as a feature of mitochondrial encephalomyopathy
191. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency
192. Nerve-muscle involvement in a large family with mitochondrial cytopathy: Electrophysiological studies
193. Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA
194. Differential diagnoses of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: An immunohistochemical approach
195. Decline in skeletal muscle mitochondrial respiratory chain function: Possible factor in aging
196. Ophthalmoplegia, demyelinating neuropathy, luekoencephalopathy, myopathy, and gastrointestinal dysfunction with multiple deletions of mitochondrial DNA: A mitochondrial multisystem disorder in search of a name
197. Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: A clinical, biochemical, and molecular study in six families
198. Cytochrome c oxidase-associated Leigh syndrome: Phenotypic features and pathogenetic speculations
199. Demonstration of a new pathogenic mutation in human complex I deficiency: A 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit
200. Mitochondrial cytopathy presenting as hereditary sensory neuropatay with progressive external ophthalmoplegia, ataxia and fatal myoclonic epileptic status
201. Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome
202. A novel mitochondrial G8313A mutation associated with prominent initial gastrointestinal symptoms and progressive encephaloneuropathy
203. A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle
204. Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue
205. Mitochondrial DNA deletions in mitochondrial cytopathies: Observations in 19 patients
206. Focal cytochrome c oxidase deficiency in various neuromuscular diseases
207. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes with recurrent abdominal symptoms and coenzyme Q10 administration
208. A case of motor and sensory neuropathy with elevated serum lactate and pyruvate which responded to large dose of coenzyme Q10 therapy
209. Peripheral neuropathy associated with mitochondrial myopathy
210. Mitochondrial cytochrome b gene deletion in Kearns-Sayre syndrome associated with a subclinical type of peripheral neuropathy
211. Mitochondrial encephalomyopathies presenting with features of autonomic and visceral dysfunction
212. Neurological presentations of mitochondrial diseases
213. Maternally inherited myopathy and cardiomyopathy: Association with mutation in mitochondrial DNA tRNA(Leu)(UUR)
214. A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene
215. Fatal infantile mitochondrial myopathy and renal dysfunction caused by cytochrome c oxidase deficiency: Immunological studies in a new patient
216. Benign reversible muscle cytochrome c oxidase deficiency: A second case
217. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region
218. Mitochondrial disorders
219. Myopathy and fatal cardiopathy due to cytochrome c oxidase deficiency
220. Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthahnoplegia plus